{"id":12060,"date":"2025-06-04T13:29:43","date_gmt":"2025-06-04T11:29:43","guid":{"rendered":"https:\/\/iph-multisite.berta-bewegt.ch\/?p=12060"},"modified":"2026-03-03T09:40:50","modified_gmt":"2026-03-03T08:40:50","slug":"3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca","status":"publish","type":"post","link":"https:\/\/www.interpharma.ch\/en\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/","title":{"rendered":"Three questions to our new board members: Florian Saur, Country General Manager Switzerland, AstraZeneca"},"content":{"rendered":"<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large is-resized\"><img decoding=\"async\" src=\"https:\/\/interpharma.ch\/wp-content\/uploads\/2025\/06\/AZ_Florian-Saur_1-1024x683.jpg\" alt=\"\" class=\"wp-image-27151\" style=\"width:528px;height:auto\"\/><\/figure>\n<\/div>\n\n\n<h2 class=\"wp-block-heading\" id=\"h-where-do-you-see-the-most-urgent-need-for-action-for-switzerland-as-a-pharmaceutical-location\"><strong>Where do you see the most urgent need for action for Switzerland as a pharmaceutical location?<\/strong><\/h2>\n\n\n\n<ol class=\"wp-block-list\"><\/ol>\n\n\n\n<p>I think the most urgent need for action is with access to innovative drugs and therapies \u2013 it\u2019s where Switzerland has to make sure it doesn\u2019t miss out. To maintain one of the best healthcare systems in the world in the future, prevention and early detection, along with integrated care programs, should also be strengthened. To achieve this, the various stakeholders in the healthcare sector need to work better together.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-and-how-would-you-like-to-get-involved-with-interpharma-here\"><strong>And how would you like to get involved with Interpharma here?<\/strong><\/h2>\n\n\n\n<p>I want to ensure that the issues are understood and taken seriously by all parties involved. I want to build on our <a href=\"https:\/\/www.srf.ch\/play\/tv\/tagesschau\/video\/tagesschau-vom-30-08-2024-hauptausgabe?urn=urn:srf:video:78c92637-78d7-459e-9f61-bfd599b1d16f&amp;startTime=1175\">media conference<\/a>, at which Interpharma was a guest, and show the political arena and society how important access to innovative medicines is for patients and the healthcare system in Switzerland. I also want to work toward ensuring that the long-term positive effect of prevention and early detection is recognized for a sustainable healthcare system, and that discussions are not only about short-term costs. At this year\u2019s Health Trend Days in Lucerne for example, we had solid discussions with national and cantonal stakeholders at our lunch event.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-the-annual-report-focused-on-the-value-of-the-pharmaceutical-industry-in-switzerland-for-patients-research-and-the-economy-which-term-spontaneously-comes-to-mind-for-the-respective-areas\"><strong>The annual report focused on the value of the pharmaceutical industry in Switzerland: for patients, research and the economy. Which term spontaneously comes to mind for the respective areas?<\/strong><\/h2>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>For patients: <\/strong>equal, fair and early access to treatments and the best possible treatment as quickly as possible<\/li>\n\n\n\n<li><strong style=\"color: initial;\">For research: <\/strong><span style=\"color: initial;\">Switzerland is known as an innovation hub \u2013 but there\u2019s still some catching up to do in the healthcare sector (for example with access, studies and digitalization)<\/span><\/li>\n\n\n\n<li><strong>For the economy: <\/strong>pharmaceuticals is a major employer; we depend on the best talents, and a good relationship with the EU is crucial<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>Where do you see the most urgent need for action for Switzerland as a pharmaceutical location? I think the most urgent need for action is with access to innovative drugs and therapies \u2013 it\u2019s where Switzerland has to make sure it doesn\u2019t miss out. To maintain one of the best healthcare systems in the world [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":3528,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"tags":[114,119,129],"class_list":["post-12060","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","tag-research","tag-innovation-en","tag-pharmastandort-2030-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.2 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Three questions to our new board members: Florian Saur, Country General Manager Switzerland, AstraZeneca - Interpharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.interpharma.ch\/en\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Three questions to our new board members: Florian Saur, Country General Manager Switzerland, AstraZeneca\" \/>\n<meta property=\"og:description\" content=\"Where do you see the most urgent need for action for Switzerland as a pharmaceutical location? I think the most urgent need for action is with access to innovative drugs and therapies \u2013 it\u2019s where Switzerland has to make sure it doesn\u2019t miss out. To maintain one of the best healthcare systems in the world [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.interpharma.ch\/en\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/\" \/>\n<meta property=\"og:site_name\" content=\"Interpharma\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-04T11:29:43+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-03T08:40:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/06\/AZ_Florian-Saur_1-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1708\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"berta_admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:site\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"berta_admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.interpharma.ch\/en\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.interpharma.ch\/en\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/\"},\"author\":{\"name\":\"berta_admin\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818\"},\"headline\":\"Three questions to our new board members: Florian Saur, Country General Manager Switzerland, AstraZeneca\",\"datePublished\":\"2025-06-04T11:29:43+00:00\",\"dateModified\":\"2026-03-03T08:40:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.interpharma.ch\/en\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/\"},\"wordCount\":322,\"publisher\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/en\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/06\/AZ_Florian-Saur_1-scaled.jpg\",\"keywords\":[\"Research\",\"Innovation\",\"Pharmastandort 2030\"],\"inLanguage\":\"en-US\",\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.interpharma.ch\/en\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/\",\"url\":\"https:\/\/www.interpharma.ch\/en\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/\",\"name\":\"Three questions to our new board members: Florian Saur, Country General Manager Switzerland, AstraZeneca - Interpharma\",\"isPartOf\":{\"@id\":\"https:\/\/www.interpharma.ch\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.interpharma.ch\/en\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/en\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/06\/AZ_Florian-Saur_1-scaled.jpg\",\"datePublished\":\"2025-06-04T11:29:43+00:00\",\"dateModified\":\"2026-03-03T08:40:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.interpharma.ch\/en\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.interpharma.ch\/en\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.interpharma.ch\/en\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/#primaryimage\",\"url\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/06\/AZ_Florian-Saur_1-scaled.jpg\",\"contentUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/06\/AZ_Florian-Saur_1-scaled.jpg\",\"width\":2560,\"height\":1708},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.interpharma.ch\/en\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/www.interpharma.ch\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Three questions to our new board members: Florian Saur, Country General Manager Switzerland, AstraZeneca\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.interpharma.ch\/#website\",\"url\":\"https:\/\/www.interpharma.ch\/\",\"name\":\"Interpharma\",\"description\":\"Verband der forschenden Pharmazeutischen Firmen\",\"publisher\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.interpharma.ch\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.interpharma.ch\/#organization\",\"name\":\"Interpharma\",\"url\":\"https:\/\/www.interpharma.ch\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"contentUrl\":\"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"width\":\"1200\",\"height\":\"1200\",\"caption\":\"Interpharma\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/interpharma_ch\",\"https:\/\/ch.linkedin.com\/company\/interpharma\",\"https:\/\/www.instagram.com\/interpharma_ch\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818\",\"name\":\"berta_admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"caption\":\"berta_admin\"},\"sameAs\":[\"https:\/\/interpharma.ch\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Three questions to our new board members: Florian Saur, Country General Manager Switzerland, AstraZeneca - Interpharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.interpharma.ch\/en\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/","og_locale":"en_US","og_type":"article","og_title":"Three questions to our new board members: Florian Saur, Country General Manager Switzerland, AstraZeneca","og_description":"Where do you see the most urgent need for action for Switzerland as a pharmaceutical location? I think the most urgent need for action is with access to innovative drugs and therapies \u2013 it\u2019s where Switzerland has to make sure it doesn\u2019t miss out. To maintain one of the best healthcare systems in the world [&hellip;]","og_url":"https:\/\/www.interpharma.ch\/en\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/","og_site_name":"Interpharma","article_published_time":"2025-06-04T11:29:43+00:00","article_modified_time":"2026-03-03T08:40:50+00:00","og_image":[{"width":2560,"height":1708,"url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/06\/AZ_Florian-Saur_1-scaled.jpg","type":"image\/jpeg"}],"author":"berta_admin","twitter_card":"summary_large_image","twitter_creator":"@interpharma_ch","twitter_site":"@interpharma_ch","twitter_misc":{"Written by":"berta_admin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.interpharma.ch\/en\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/#article","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/en\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/"},"author":{"name":"berta_admin","@id":"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818"},"headline":"Three questions to our new board members: Florian Saur, Country General Manager Switzerland, AstraZeneca","datePublished":"2025-06-04T11:29:43+00:00","dateModified":"2026-03-03T08:40:50+00:00","mainEntityOfPage":{"@id":"https:\/\/www.interpharma.ch\/en\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/"},"wordCount":322,"publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"image":{"@id":"https:\/\/www.interpharma.ch\/en\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/06\/AZ_Florian-Saur_1-scaled.jpg","keywords":["Research","Innovation","Pharmastandort 2030"],"inLanguage":"en-US","copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/www.interpharma.ch\/#organization"}},{"@type":"WebPage","@id":"https:\/\/www.interpharma.ch\/en\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/","url":"https:\/\/www.interpharma.ch\/en\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/","name":"Three questions to our new board members: Florian Saur, Country General Manager Switzerland, AstraZeneca - Interpharma","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.interpharma.ch\/en\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/#primaryimage"},"image":{"@id":"https:\/\/www.interpharma.ch\/en\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/06\/AZ_Florian-Saur_1-scaled.jpg","datePublished":"2025-06-04T11:29:43+00:00","dateModified":"2026-03-03T08:40:50+00:00","breadcrumb":{"@id":"https:\/\/www.interpharma.ch\/en\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.interpharma.ch\/en\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.interpharma.ch\/en\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/#primaryimage","url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/06\/AZ_Florian-Saur_1-scaled.jpg","contentUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/06\/AZ_Florian-Saur_1-scaled.jpg","width":2560,"height":1708},{"@type":"BreadcrumbList","@id":"https:\/\/www.interpharma.ch\/en\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.interpharma.ch\/en\/"},{"@type":"ListItem","position":2,"name":"Three questions to our new board members: Florian Saur, Country General Manager Switzerland, AstraZeneca"}]},{"@type":"WebSite","@id":"https:\/\/www.interpharma.ch\/#website","url":"https:\/\/www.interpharma.ch\/","name":"Interpharma","description":"Verband der forschenden Pharmazeutischen Firmen","publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.interpharma.ch\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.interpharma.ch\/#organization","name":"Interpharma","url":"https:\/\/www.interpharma.ch\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/","url":"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","contentUrl":"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","width":"1200","height":"1200","caption":"Interpharma"},"image":{"@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/interpharma_ch","https:\/\/ch.linkedin.com\/company\/interpharma","https:\/\/www.instagram.com\/interpharma_ch\/"]},{"@type":"Person","@id":"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818","name":"berta_admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","caption":"berta_admin"},"sameAs":["https:\/\/interpharma.ch"]}]}},"_links":{"self":[{"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/posts\/12060","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/comments?post=12060"}],"version-history":[{"count":1,"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/posts\/12060\/revisions"}],"predecessor-version":[{"id":12061,"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/posts\/12060\/revisions\/12061"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/media\/3528"}],"wp:attachment":[{"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/media?parent=12060"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/tags?post=12060"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}